WebMay 11, 2024 · for the German PTLD Study Group and German Lymphoma Alliance. Contributions. HZ, MN, and RUT designed the study. RUT is the principal investigator and takes primary responsibility for the paper. HZ, MN, CP, PR, NB, RMH, IAH, DH, MR, and RUT recruited and treated significant numbers of patients. HZ, MN, and RUT collected, … WebGerman Lymphoma Alliance e.V. GLA-Geschäftsstelle c/o DGHO Service GmbH, Frau Steffi Heinecke (Mitgliederverwaltung, Finanzen, Veranstaltungsorganisation, Termine) E …
Author notes - American Society of Hematology
WebNov 22, 2024 · Treatment with CD19-directed CAR T-cells has evolved as a standard of care for relapsed or refractory large B-cell lymphoma (r/r LBCL). As LBCL is largely a disease of the elderly, age limitations ... WebDie German Lymphoma Alliance e.V. setzt sich als gemeinnütziger Verein zum Ziel, die Therapieergebnisse für Patienten mit malignem Lymphom in Deutschland nachhaltig zu … Studien - German Lymphoma Alliance Register - German Lymphoma Alliance Arbeitsgruppen - German Lymphoma Alliance Für Patienten - German Lymphoma Alliance Termine - German Lymphoma Alliance Über uns - German Lymphoma Alliance Ansprechpartner - German Lymphoma Alliance Organisationen - German Lymphoma Alliance Sponsoren - German Lymphoma Alliance Publikationen - German Lymphoma Alliance gif jim carrey gagging
German Lymphoma Alliance (GLA) - Kompetenznetz Maligne …
WebDec 21, 2024 · Poeschel V, Held G, Ziepert M, et al; FLYER Trial Investigators; German Lymphoma Alliance. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. WebMethods: A multi-item questionnaire containing multiple-choice and free-text questions was developed in a peer-reviewed process and sent to members of the radiation oncology … WebJun 2, 2024 · Sensitivity and specificity of minimal residual disease for early detection of disease progression is an exploratory endpoint; further MRD parameters may also be investigated. The study is funded by MorphoSys AG and conducted with the scientific support of members of the Fondazione Italiana Linfomi and the German Lymphoma … fruity chypre